North America Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

Description

List of Tables

GlobalData's "North America Metabolic Disorders Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays and Cholesterol Tests

The North America Metabolic Disorders Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Metabolic Disorders Market.
Global corporate-level profiles of key companies operating within the North America Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Metabolic Disorders is segmented as follows -

Diabetes Assays
Cholesterol Tests

Reasons to Buy

The North America Metabolic Disorders Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Product Code: GDME20426CRDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Metabolic Disorders Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Metabolic Disorders Market, North America

3.1 Metabolic Disorders Market, North America, Revenue ($m), 2018-2033
3.2 Metabolic Disorders Market, North America, Revenue ($m), 2018-2033
3.3 Metabolic Disorders Market, North America, Volume (Units), 2018-2033
3.4 Metabolic Disorders Market, North America, Volume (Units), 2018-2033
3.5 Metabolic Disorders Market, North America, Company Share by Revenue ($m), 2024

4 Metabolic Disorders Market, Canada

4.1 Metabolic Disorders Market, Canada, Revenue ($m), 2018-2033
- 4.1.1 Cholesterol Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
- 4.1.2 Diabetes Assays Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Metabolic Disorders Market, Canada, Volume (Units), 2018-2033
- 4.2.1 Cholesterol Tests Market, Canada, Volume (Units), by Segment, 2018-2033
- 4.2.2 Diabetes Assays Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Metabolic Disorders Market, Canada, Average Price ($), 2018-2033
4.4 Metabolic Disorders Market, Canada, Company Share by Revenue ($m), 2024

5 Metabolic Disorders Market, United States

5.1 Metabolic Disorders Market, United States, Revenue ($m), 2018-2033
- 5.1.1 Cholesterol Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 5.1.2 Diabetes Assays Market, United States, Revenue ($m), by Segment, 2018-2033
5.2 Metabolic Disorders Market, United States, Volume (Units), 2018-2033
- 5.2.1 Cholesterol Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 5.2.2 Diabetes Assays Market, United States, Volume (Units), by Segment, 2018-2033
5.3 Metabolic Disorders Market, United States, Average Price ($), 2018-2033
5.4 Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024

6 Metabolic Disorders Market, Mexico

6.1 Metabolic Disorders Market, Mexico, Revenue ($m), 2018-2033
- 6.1.1 Cholesterol Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 6.1.2 Diabetes Assays Market, Mexico, Revenue ($m), by Segment, 2018-2033
6.2 Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033
- 6.2.1 Cholesterol Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
- 6.2.2 Diabetes Assays Market, Mexico, Volume (Units), by Segment, 2018-2033
6.3 Metabolic Disorders Market, Mexico, Average Price ($), 2018-2033
6.4 Metabolic Disorders Market, Mexico, Company Share by Revenue ($m), 2024

7 Overview of Key Companies in North America Metabolic Disorders Market

7.1 Abbott Laboratories
- 7.1.1 Company Overview
7.2 Siemens Healthineers AG
- 7.2.1 Company Overview
7.3 Beckman Coulter Inc
- 7.3.1 Company Overview
7.4 Ortho Clinical Diagnostics Holdings Plc
- 7.4.1 Company Overview
7.5 Roche Diagnostics International Ltd
- 7.5.1 Company Overview
7.6 Bio-Rad Laboratories Inc
- 7.6.1 Company Overview

8 Metabolic Disorders Market Pipeline Products

9 Recent Developments

9.1 Product News
- 9.1.1 May 21, 2025: MedImpact Unveils MedEmpower Fuel AI Plate Scanner
- 9.1.2 Mar 21, 2025: Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
- 9.1.3 Jan 06, 2025: Introducing isaac by PreEvnt - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit
9.2 Strategy And Business Planning
- 9.2.1 Jul 17, 2024: New Opportunity to Improve Diagnosis Care for People with Cardiovascular-Kidney-Metabolic Syndrome

10 Appendix

10.1 Research Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Market Modeling and Forecasting
- 10.1.5 Company Share Analysis
- 10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer

Product Code: GDME20426CRDB

List of Table

List of Tables

Table 1: Metabolic Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Metabolic Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Metabolic Disorders Market, North America, Volume (Units), 2018-2033
Table 4: Metabolic Disorders Market, North America, Volume (Units), 2018-2033
Table 5: Metabolic Disorders Market, North America, Company Share by Revenue ($m), 2024
Table 6: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Metabolic Disorders Market, Canada, Volume (Units), 2018-2033
Table 10: Cholesterol Tests Market, Canada, Volume (Units), 2018-2033
Table 11: Diabetes Assays Market, Canada, Volume (Units), 2018-2033
Table 12: Metabolic Disorders Market, Canada, Average Price ($), 2018-2033
Table 13: Metabolic Disorders Market, Canada, Company Share by Revenue ($m), 2024
Table 14: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 15: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 16: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 17: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
Table 18: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
Table 19: Diabetes Assays Market, United States, Volume (Units), 2018-2033
Table 20: Metabolic Disorders Market, United States, Average Price ($), 2018-2033
Table 21: Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024
Table 22: Metabolic Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 23: Cholesterol Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 24: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 25: Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033
Table 26: Cholesterol Tests Market, Mexico, Volume (Units), 2018-2033
Table 27: Diabetes Assays Market, Mexico, Volume (Units), 2018-2033
Table 28: Metabolic Disorders Market, Mexico, Average Price ($), 2018-2033
Table 29: Metabolic Disorders Market, Mexico, Company Share by Revenue ($m), 2024
Table 36: Metabolic Disorders Market Pipeline Products
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

Figure 1: Metabolic Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Metabolic Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Metabolic Disorders Market, North America, Volume (Units), 2018-2033
Figure 4: Metabolic Disorders Market, North America, Volume (Units), 2018-2033
Figure 5: Metabolic Disorders Market, North America, Company Share (%), 2024
Figure 6: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: Metabolic Disorders Market, Canada, Volume (Units), 2018-2033
Figure 10: Cholesterol Tests Market, Canada, Volume (Units), 2018-2033
Figure 11: Diabetes Assays Market, Canada, Volume (Units), 2018-2033
Figure 12: Metabolic Disorders Market, Canada, Company Share (%), 2024
Figure 13: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 14: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 15: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 16: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
Figure 17: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
Figure 18: Diabetes Assays Market, United States, Volume (Units), 2018-2033
Figure 19: Metabolic Disorders Market, United States, Company Share (%), 2024
Figure 20: Metabolic Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 21: Cholesterol Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 22: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 23: Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033
Figure 24: Cholesterol Tests Market, Mexico, Volume (Units), 2018-2033
Figure 25: Diabetes Assays Market, Mexico, Volume (Units), 2018-2033
Figure 26: Metabolic Disorders Market, Mexico, Company Share (%), 2024